Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Intec Parent Inc (NTEC)

Intec Parent Inc (NTEC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,138
  • Shares Outstanding, K 898
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,130 K
  • 60-Month Beta 0.89
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.07
Trade NTEC with:

Options Overview

Details
  • Implied Volatility 0.00%
  • Historical Volatility 202.13%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -4.00
  • Growth Rate Est. (year over year) +25,075.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.86 +8.69%
on 07/28/21
17.80 -45.90%
on 07/29/21
-4.33 (-31.02%)
since 07/02/21
3-Month
8.86 +8.69%
on 07/28/21
21.36 -54.92%
on 05/11/21
-5.81 (-37.63%)
since 05/03/21
52-Week
8.80 +9.43%
on 10/30/20
36.88 -73.89%
on 08/04/20
-23.47 (-70.91%)
since 08/03/20

Most Recent Stories

More News
Intec Closes Merger with Decoy Biosystems

/PRNewswire/ -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company," and formerly, , Inc.) today announced the closing of its previously announced merger with Decoy Biosystems, Inc....

NTEC : 9.63 (-12.48%)
Intec Announces Expected Closing Date of Decoy Merger

/PRNewswire/ -- , Inc. (NASDAQ: NTEC) ("" or the "Company"), today announced that the pending and previously announced reverse merger (the "Decoy Merger") with Decoy Biosystems, Inc. ("Decoy") is currently...

NTEC : 9.63 (-12.48%)
Intec Announces $30 Million Private Placement Ahead of Decoy Merger

/PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("" or the "Company"), today announced that its wholly-owned subsidiary, , Inc. ("Intec US"), entered into a securities purchase agreement with a single,...

NTEC : 9.63 (-12.48%)
Thinking about buying stock in Fisker, Torchlight Energy, Intec Pharma, Supernus Pharmaceuticals, or Cyclo Therapeutics?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FSR, TRCH, NTEC, SUPN, and CYTH.

CYTH : 8.28 (-2.70%)
SUPN : 26.89 (+0.56%)
NTEC : 9.63 (-12.48%)
TRCH : 4.95 (+4.21%)
FSR : 14.80 (-7.27%)
Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels

PALM BEACH,  Fla., /PRNewswire/ --  The recent pandemic has, as we all know, negatively affected almost every business and financial markets across the globe… and even the seemingly ever increasing...

RTSL : 0.3755 (-6.13%)
JAZZ : 171.50 (+0.46%)
NTEC : 9.63 (-12.48%)
CARA : 11.67 (-3.95%)
ARNA : 60.43 (-0.10%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates PRAH, WSFS, STAY, NTEC, MX; Shareholders are Encouraged to Contact the Firm

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

NTEC : 9.63 (-12.48%)
PRAH : 165.21 (-1.67%)
WSFS : 43.81 (+1.51%)
STAY : 20.46 (unch)
MX : 20.90 (+0.48%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTEC, RMBL, STAY, and LDKB Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

NTEC : 9.63 (-12.48%)
RMBL : 37.90 (-2.47%)
STAY : 20.46 (unch)
LDKB : 18.2000 (+2.25%)
Thinking about buying stock in Intec Pharma, Energous Corp, International Game Technology, 3D Systems, or Precipio?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NTEC, WATT, IGT, DDD, and PRPO.

NTEC : 9.63 (-12.48%)
PRPO : 3.22 (+3.87%)
WATT : 2.49 (-2.92%)
DDD : 26.60 (-3.31%)
IGT : 19.12 (+0.74%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - NTEC, SNX, STAY, MX, MLND

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

NTEC : 9.63 (-12.48%)
SNX : 119.50 (+1.46%)
STAY : 20.46 (unch)
MX : 20.90 (+0.48%)
MLND : 1.0600 (-5.36%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTEC, RMBL, STAY, and LDKB Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

NTEC : 9.63 (-12.48%)
RMBL : 37.90 (-2.47%)
STAY : 20.46 (unch)
LDKB : 18.2000 (+2.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Intec Pharma Ltd. is a biopharmaceutical company. The company focused on developing drugs through proprietary Accordion Pill platform technology. Its product candidates in clinical trial stages consists of Accordion Pill Carbidopa/Levodopa developed for the indication of treatment of Parkinson's disease...

See More

Key Turning Points

3rd Resistance Point 12.13
2nd Resistance Point 11.61
1st Resistance Point 10.62
Last Price 9.63
1st Support Level 9.11
2nd Support Level 8.60
3rd Support Level 7.61

See More

52-Week High 36.88
Fibonacci 61.8% 26.15
Fibonacci 50% 22.84
Fibonacci 38.2% 19.53
Last Price 9.63
52-Week Low 8.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar